(INN) Summit Hotel Properties - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8660821005
Stock: Hotels, Guestrooms, Premium-Branded, Upscale
Total Rating 26
Risk 54
Buy Signal -1.16
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.05% |
| Yield on Cost 5y | 5.43% |
| Yield CAGR 5y | 58.74% |
| Payout Consistency | 82.5% |
| Payout Ratio | 160.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Relative Tail Risk | -8.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -54.10 |
| Character TTM | |
|---|---|
| Beta | 1.631 |
| Beta Downside | 1.824 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.67% |
| CAGR/Max DD | -0.31 |
Description: INN Summit Hotel Properties December 26, 2025
Summit Hotel Properties, Inc. (NYSE: INN) is a U.S.-based REIT that owns and operates premium-branded hotels, mainly in the upscale segment. As of August 5 2025 the company held 97 hotel assets-53 wholly owned-comprising 14,577 guestrooms across 25 states.
Key industry metrics that currently influence Summit’s performance include an average occupancy of 71% and a RevPAR of roughly $112 in Q2 2025, both tracking modestly above the 2024-2025 upscale hotel sub-industry averages (≈ 68% occupancy, $108 RevPAR). The REIT’s leverage stands at a debt-to-EBITDA ratio of 4.2×, and its weighted-average cost of capital is sensitive to Federal Reserve policy, as a 25 bp rise in rates typically compresses net operating income by 1–2% for highly leveraged hotel REITs.
For a deeper dive into how these fundamentals compare with peers and to explore valuation angles, you might find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 1.58m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: 1.31% < 20% (prev 1.66%; Δ -0.35% < -1%) |
| CFO/TA 0.05 > 3% & CFO 152.7m > Net Income 1.58m |
| Net Debt (1.41b) to EBITDA (211.4m): 6.65 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.9m) vs 12m ago -0.14% < -2% |
| Gross Margin: 33.85% > 18% (prev 0.36%; Δ 3349 % > 0.5%) |
| Asset Turnover: 25.59% > 50% (prev 25.95%; Δ -0.36% > 0%) |
| Interest Coverage Ratio: 0.77 > 6 (EBITDA TTM 211.4m / Interest Expense TTM 81.1m) |
Altman Z'' -0.54
| A: 0.00 (Total Current Assets 112.3m - Total Current Liabilities 102.8m) / Total Assets 2.85b |
| B: -0.14 (Retained Earnings -390.9m / Total Assets 2.85b) |
| C: 0.02 (EBIT TTM 62.8m / Avg Total Assets 2.84b) |
| D: -0.25 (Book Value of Equity -386.8m / Total Liabilities 1.55b) |
| Altman-Z'' Score: -0.54 = B |
Beneish M -3.09
| DSRI: 0.93 (Receivables 19.0m/20.7m, Revenue 727.4m/736.3m) |
| GMI: 1.06 (GM 33.85% / 35.82%) |
| AQI: 1.00 (AQ_t 0.95 / AQ_t-1 0.95) |
| SGI: 0.99 (Revenue 727.4m / 736.3m) |
| TATA: -0.05 (NI 1.58m - CFO 152.7m) / TA 2.85b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of INN shares?
As of January 30, 2026, the stock is trading at USD 4.47 with a total of 754,908 shares traded.
Over the past week, the price has changed by -7.45%, over one month by -8.59%, over three months by -13.75% and over the past year by -29.40%.
Over the past week, the price has changed by -7.45%, over one month by -8.59%, over three months by -13.75% and over the past year by -29.40%.
Is INN a buy, sell or hold?
Summit Hotel Properties has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold INN.
- StrongBuy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.6 | 26% |
| Analysts Target Price | 5.6 | 26% |
| ValueRay Target Price | 4.6 | 2.7% |
INN Fundamental Data Overview January 29, 2026
P/S = 0.6866
P/B = 0.5815
Revenue TTM = 727.4m USD
EBIT TTM = 62.8m USD
EBITDA TTM = 211.4m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 210.0m USD (from shortTermDebt, last fiscal year)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 1.90b USD (499.4m + Debt 1.45b - CCE 41.1m)
Interest Coverage Ratio = 0.77 (Ebit TTM 62.8m / Interest Expense TTM 81.1m)
EV/FCF = 15.25x (Enterprise Value 1.90b / FCF TTM 124.9m)
FCF Yield = 6.56% (FCF TTM 124.9m / Enterprise Value 1.90b)
FCF Margin = 17.17% (FCF TTM 124.9m / Revenue TTM 727.4m)
Net Margin = 0.22% (Net Income TTM 1.58m / Revenue TTM 727.4m)
Gross Margin = 33.85% ((Revenue TTM 727.4m - Cost of Revenue TTM 481.2m) / Revenue TTM)
Gross Margin QoQ = 30.56% (prev 35.41%)
Tobins Q-Ratio = 0.67 (Enterprise Value 1.90b / Total Assets 2.85b)
Interest Expense / Debt = 1.43% (Interest Expense 20.7m / Debt 1.45b)
Taxrate = 21.0% (US default 21%)
NOPAT = 49.6m (EBIT 62.8m * (1 - 21.00%))
Current Ratio = 1.09 (Total Current Assets 112.3m / Total Current Liabilities 102.8m)
Debt / Equity = 1.65 (Debt 1.45b / totalStockholderEquity, last quarter 875.8m)
Debt / EBITDA = 6.65 (Net Debt 1.41b / EBITDA 211.4m)
Debt / FCF = 11.25 (Net Debt 1.41b / FCF TTM 124.9m)
Total Stockholder Equity = 900.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.06% (Net Income 1.58m / Total Assets 2.85b)
RoE = 0.18% (Net Income TTM 1.58m / Total Stockholder Equity 900.2m)
RoCE = 2.70% (EBIT 62.8m / Capital Employed (Equity 900.2m + L.T.Debt 1.42b))
RoIC = 2.14% (NOPAT 49.6m / Invested Capital 2.32b)
WACC = 3.90% (E(499.4m)/V(1.95b) * Re(11.92%) + D(1.45b)/V(1.95b) * Rd(1.43%) * (1-Tc(0.21)))
Discount Rate = 11.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 87.20% ; FCFF base≈130.5m ; Y1≈143.1m ; Y5≈181.9m
Fair Price DCF = 36.47 (EV 5.37b - Net Debt 1.41b = Equity 3.97b / Shares 108.8m; r=5.90% [WACC]; 5y FCF grow 10.99% → 2.90% )
EPS Correlation: 2.90 | EPS CAGR: 42.03% | SUE: 0.99 | # QB: 1
Revenue Correlation: 55.09 | Revenue CAGR: 14.42% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.08 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.50 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=-61.3% | Growth Revenue=+2.0%
P/B = 0.5815
Revenue TTM = 727.4m USD
EBIT TTM = 62.8m USD
EBITDA TTM = 211.4m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 210.0m USD (from shortTermDebt, last fiscal year)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 1.90b USD (499.4m + Debt 1.45b - CCE 41.1m)
Interest Coverage Ratio = 0.77 (Ebit TTM 62.8m / Interest Expense TTM 81.1m)
EV/FCF = 15.25x (Enterprise Value 1.90b / FCF TTM 124.9m)
FCF Yield = 6.56% (FCF TTM 124.9m / Enterprise Value 1.90b)
FCF Margin = 17.17% (FCF TTM 124.9m / Revenue TTM 727.4m)
Net Margin = 0.22% (Net Income TTM 1.58m / Revenue TTM 727.4m)
Gross Margin = 33.85% ((Revenue TTM 727.4m - Cost of Revenue TTM 481.2m) / Revenue TTM)
Gross Margin QoQ = 30.56% (prev 35.41%)
Tobins Q-Ratio = 0.67 (Enterprise Value 1.90b / Total Assets 2.85b)
Interest Expense / Debt = 1.43% (Interest Expense 20.7m / Debt 1.45b)
Taxrate = 21.0% (US default 21%)
NOPAT = 49.6m (EBIT 62.8m * (1 - 21.00%))
Current Ratio = 1.09 (Total Current Assets 112.3m / Total Current Liabilities 102.8m)
Debt / Equity = 1.65 (Debt 1.45b / totalStockholderEquity, last quarter 875.8m)
Debt / EBITDA = 6.65 (Net Debt 1.41b / EBITDA 211.4m)
Debt / FCF = 11.25 (Net Debt 1.41b / FCF TTM 124.9m)
Total Stockholder Equity = 900.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.06% (Net Income 1.58m / Total Assets 2.85b)
RoE = 0.18% (Net Income TTM 1.58m / Total Stockholder Equity 900.2m)
RoCE = 2.70% (EBIT 62.8m / Capital Employed (Equity 900.2m + L.T.Debt 1.42b))
RoIC = 2.14% (NOPAT 49.6m / Invested Capital 2.32b)
WACC = 3.90% (E(499.4m)/V(1.95b) * Re(11.92%) + D(1.45b)/V(1.95b) * Rd(1.43%) * (1-Tc(0.21)))
Discount Rate = 11.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 87.20% ; FCFF base≈130.5m ; Y1≈143.1m ; Y5≈181.9m
Fair Price DCF = 36.47 (EV 5.37b - Net Debt 1.41b = Equity 3.97b / Shares 108.8m; r=5.90% [WACC]; 5y FCF grow 10.99% → 2.90% )
EPS Correlation: 2.90 | EPS CAGR: 42.03% | SUE: 0.99 | # QB: 1
Revenue Correlation: 55.09 | Revenue CAGR: 14.42% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.08 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.50 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=-61.3% | Growth Revenue=+2.0%